title: From active surveillance to the concept of secondary prevention.
authors.forename: Olivier
authors.initials: O
authors.lastname: Cussenot
authors.forename: Eva
authors.initials: E
authors.lastname: Comperat
authors.forename: Marc-Olivier
authors.initials: MO
authors.lastname: Bitker
authors.forename: Morgan
authors.initials: M
authors.lastname: Rouprêt
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011159:Population Surveillance; D011471:Prostatic Neoplasms / Q000401:mortality* / Q000517:prevention & control* / Q000628:therapy
chemical_list: D000726:Androgen Antagonists; D004791:Enzyme Inhibitors